← Back
$ANIP All transactions

ANI PHARMACEUTICALS INC

F

$ Value

$38K

Shares

485

Price

$77

Filed

Feb 17

Insider

Name

Rowland Thomas Andrew

Title

SVP, HEAD - ESTABLISHED BRANDS

CIK

0001507496

Roles

Officer

Transaction Details

Transaction Date

2026-02-14

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

38,109

Footnotes

Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,958 shares of restricted stock, the grant of which was previously reported. | Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,677 shares of restricted stock, the grant of which was previously reported.

Filing Info

Accession No.

0001507496-26-000005

Form Type

4

Issuer CIK

0001023024

Rowland Thomas Andrew's History

Date Ticker Type Value
2026-03-11 ANIP $357K
2026-02-28 ANIP F $46K
2026-02-26 ANIP A $465K
2026-02-14 ANIP F $38K
2026-02-12 ANIP F $43K
2026-02-11 ANIP F $134K
2025-08-12 ANIP $426K

Other Insiders at ANIP (90d)

Insider Bought Sold Last
Rowland Thomas Andrew
SVP, HEAD - ESTABLISHED BRANDS
$357K 2026-03-11
CAREY STEPHEN P.
SVP & CFO
$552K 2026-03-07
Walsh Patrick D $445K 2026-03-03
Lalwani Nikhil
PRESIDENT & CEO
2026-03-07
Gutwerg Ori
SVP, GENERICS
$158K 2026-03-07
Mutz Christopher
HEAD OF RARE DISEASE
$1.6M 2026-03-13
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
2026-02-26
Gassert Chad
SVP - CORP. DEV. & STRATEGY
2026-02-28
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
$114K 2026-04-13
Davis Krista
SVP, CHIEF HR OFFICER
$785K 2026-03-09